SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 685.16 |
Enterprise Value ($M) | 560.19 |
Book Value ($M) | 502.75 |
Book Value / Share | 4.96 |
Price / Book | 1.36 |
NCAV ($M) | 482.29 |
NCAV / Share | 4.76 |
Price / NCAV | 1.42 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.19 |
Return on Assets (ROA) | -0.29 |
Return on Equity (ROE) | -0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 7.61 |
Current Ratio | 7.66 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 562.33 |
Assets | 582.79 |
Liabilities | 80.04 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 131.16 |
Operating Income | -212.27 |
Net Income | -95.50 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -78.11 |
Cash from Investing | -230.99 |
Cash from Financing | 203.29 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Ra Capital Management, L.p. | 5.70 | -26.30 | |
13G/A | Fmr Llc | 12.80 | 14.18 | |
13G/A | Atlas Venture Fund XI, L.P. | 5.50 | -19.48 | |
13D/A | AI Day1 LLC | 13.15 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
f UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
214,902 | 1,185,774 | 18.12 | |
237,098 | 1,124,781 | 21.08 | |
834,452 | 1,998,336 | 41.76 | |
343,156 | 1,056,139 | 32.49 | |
310,323 | 1,209,052 | 25.67 | |
(click for more detail) |
Similar Companies | |
---|---|
CRNX – Crinetics Pharmaceuticals, Inc. | CTMX – CytomX Therapeutics, Inc. |
CYTK – Cytokinetics, Incorporated | DNLI – Denali Therapeutics Inc. |
DSGN – Design Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io